Loading...

Analysts Mixed on Wacker Chemie as Price Targets Fall Amid Slightly Lower Growth Forecasts

Published
22 Dec 24
Updated
02 May 26
Views
153
n/a
n/a
AnalystConsensusTarget's Fair Value
n/a
Loading
1Y
38.9%
7D
-1.9%

Author's Valuation

€81.4315.0% overvalued intrinsic discount

AnalystConsensusTarget Fair Value

Last Update 02 May 26

Fair value Increased 11%

WCH: Future Returns Will Depend On Delivering Cautious 2026 Earnings Guidance

Analysts have lifted their fair value estimate for Wacker Chemie from €73.50 to about €81.43, citing updated assumptions on revenue growth, profitability and future P/E multiples following several recent upgrades and price target increases from major research houses.

Analyst Commentary

Bullish Takeaways

  • Bullish analysts point to a series of recent upgrades as support for a higher fair value range, linking their stance to refreshed assumptions on revenue, margins and the P/E multiple they are willing to apply.
  • Several price targets have been set above earlier levels, including a move to €61 from €59 at one major global bank, which analysts view as consistent with a modestly stronger execution outlook than previously modeled.
  • Recent upgrades are framed around a more constructive view of how Wacker Chemie can convert its existing operations into earnings, which in turn feeds into higher long term earnings power in their valuation work.
  • The clustering of positive rating and target changes is being used by bullish analysts as a signal that prior expectations may have been too conservative, especially around the company’s ability to support its current earnings base.

Bearish Takeaways

  • Some bearish analysts maintain cautious stances even when adjusting targets, as shown by the retention of an Underweight rating alongside the €61 target, which suggests they still see limited upside at current valuation levels.
  • Cautious views often highlight execution risk, arguing that the uplift in targets is tied to model changes rather than clear new evidence on operational delivery, which could leave estimates vulnerable if assumptions do not play out.
  • There is concern that applying richer P/E multiples without a clear shift in the risk profile could expose investors to downside if sentiment turns or if earnings do not align with the updated assumptions.
  • Some bearish analysts see the wave of upgrades as largely bringing valuations closer to prevailing market expectations rather than creating a clear margin of safety, which tempers enthusiasm for aggressive positioning in the shares.

What's in the News

  • Wacker Chemie issued earnings guidance for the first quarter of 2026, indicating expected sales of about €1.35b, providing a reference point for near term revenue expectations (Key Developments).
  • The company also provided guidance for full year 2026, describing group sales as expected to increase by a low single digit percentage (Key Developments).

Valuation Changes

  • Fair Value was raised from €73.50 to about €81.43, reflecting a higher central estimate for the shares.
  • The Discount Rate moved slightly lower from 6.31% to about 6.15%, implying a marginally lower required return in the updated model.
  • Revenue Growth was adjusted from about 2.84% to roughly 3.58%, indicating a slightly stronger top line profile in the new assumptions.
  • The Profit Margin was refined from about 3.12% to roughly 3.14%, a small change that still influences earnings output when projected over time.
  • The Future P/E was lifted from about 23.68x to roughly 25.44x, pointing to a somewhat higher multiple applied to expected earnings in the revised valuation work.
0 viewsusers have viewed this narrative update

Key Takeaways

  • Strategic investments and focus on high-value specialty products position Wacker for long-term growth in renewables and advanced electronics markets.
  • Emphasis on sustainability, cost optimization, and regulatory tailwinds is expected to drive improved margins and resilient earnings.
  • Softer demand, rising competition, currency pressures, and regulatory uncertainty are undermining profitability and growth while high fixed costs threaten margins if utilization does not improve.

Catalysts

About Wacker Chemie
    Provides chemical products worldwide.
What are the underlying business or industry changes driving this perspective?
  • Completion of major strategic investments and new polysilicon and specialty chemicals capacities positions Wacker to benefit long term from rising demand in renewable energy (solar and battery storage) and advanced electronics, likely supporting higher revenue growth and operational leverage once demand recovers.
  • Accelerated shift in product mix toward high-value, specialty silicones and sustainable solutions (including biosolutions), combined with focused innovation and digitization initiatives, is expected to improve net margins over the next business cycle as Wacker moves away from more commoditized, lower-margin products.
  • Proactive cost reduction and cash optimization measures, including reduced CapEx, working capital improvements, and plant productivity initiatives, should enhance free cash flow and earnings resilience, particularly as volumes recover or economic headwinds abate.
  • Broader global momentum toward decarbonization and customer focus on sustainable supply chains (highlighted by positive response to Wacker's new carbon footprint tool) will likely drive structurally higher demand for Wacker's eco-friendly and energy-efficient materials, underpinning long-term revenue growth.
  • Regulatory and policy developments in key markets (such as potential Section 232 in the U.S., possible reductions in Chinese polysilicon overcapacity, or supportive EU/German industrial policy) could improve industry pricing power and market access, acting as catalysts for earnings upside if implemented.
Wacker Chemie Earnings and Revenue Growth

Wacker Chemie Future Earnings and Revenue Growth

Assumptions

How have these above catalysts been quantified?

  • Analysts are assuming Wacker Chemie's revenue will grow by 3.6% annually over the next 3 years.
  • Analysts assume that profit margins will increase from -15.0% today to 3.1% in 3 years time.
  • Analysts expect earnings to reach €191.4 million (and earnings per share of €3.54) by about May 2029, up from -€821.1 million today. However, there is a considerable amount of disagreement amongst the analysts with the most bullish expecting €299.4 million in earnings, and the most bearish expecting €125.9 million.
  • In order for the above numbers to justify the price target of the analysts, the company would need to trade at a PE ratio of 25.7x on those 2029 earnings, up from -5.7x today. This future PE is lower than the current PE for the GB Chemicals industry at 26.5x.
  • Analysts expect the number of shares outstanding to grow by 0.61% per year for the next 3 years.
  • To value all of this in today's terms, we will use a discount rate of 6.15%, as per the Simply Wall St company report.

Risks

What could happen that would invalidate this narrative?
  • Persistent weak demand and heightened competition across Wacker's core markets-particularly in silicones, polymers, and solar-grade polysilicon-are driving sequential and year-over-year declines in revenue and EBITDA, raising risk of prolonged revenue stagnation if these secular headwinds do not abate.
  • Significant currency headwinds, especially from an unfavorable euro-U.S. dollar exchange rate and limited long-term hedging, are compressing both reported revenues and EBITDA, with further strengthening of the euro potentially eroding international earnings.
  • Structural overcapacity and intense price competition in the polysilicon market-exacerbated by Chinese producers-continue to weigh on pricing power and capacity utilization, risking future impairments, lower profitability, and reduced earnings in Wacker's key segments.
  • Recent major capital investments have increased depreciation and fixed costs, resulting in underutilized assets and lower gross profit margins as top-line growth stalls; if asset utilization does not improve, net margins and free cash flow are likely to stay pressured.
  • The company faces mounting regulatory and geopolitical uncertainty-including trade policy volatility, energy pricing reforms, and unresolved outcomes of U.S. trade investigations like Section 232-which could unpredictably impact long-term access to key markets, input costs, and revenue streams.

Valuation

How have all the factors above been brought together to estimate a fair value?

  • The analysts have a consensus price target of €81.43 for Wacker Chemie based on their expectations of its future earnings growth, profit margins and other risk factors.
  • However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of €110.0, and the most bearish reporting a price target of just €50.0.
  • In order for you to agree with the analysts, you'd need to believe that by 2029, revenues will be €6.1 billion, earnings will come to €191.4 million, and it would be trading on a PE ratio of 25.7x, assuming you use a discount rate of 6.1%.
  • Given the current share price of €93.65, the analyst price target of €81.43 is 15.0% lower. Despite analysts expecting the underlying business to improve, they seem to believe the market's expectations are too high.
  • We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.

Have other thoughts on Wacker Chemie?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

How well do narratives help inform your perspective?

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.

Read more narratives